Oddly (or perhaps not so), The Motley Fool is running a headline -- on its current Merck dividend levels story -- that would suggest the opposite of the conclusion the story actually reaches.
Anything to garner eyeballs, I gather -- here is The Fools' bottom line [after the misleading headline]:
How Long Will Merck's Dividend Last?
. . . .However, when we look at Merck's payout ratio compared to its peer average, we see that it is a lower percentage, which illustrates that its dividend is probably more sustainable [than that of its peers]. . . .
Nothing in the recent analyses I've undertaken would suggest that Merck would ever imperil the dividend. It isn't likely to up the payout, either -- but Whitehouse Station, and heir apparent Ken Frazier well knows that a $34-plus handle on the stock will require at least this current level of dividend support. Bank on that.
No comments:
Post a Comment